Approval · Notice of Compliance 15662 · 2014
TACTUPUMP: Notice of Compliance 15662
Issued May 28, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15662
- Date
- May 28, 2014
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extend the patient population to 9 years and over
- Therapeutic class
- Acne therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TACTUPUMP | Not yet assigned | — |
Medicinal ingredients
- BENZOYL PEROXIDE 25 MG per G
- ADAPALENE 1 MG per G